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ABSTRACT 
Granisetron hydrochloride is a novel serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following 
chemotherapy. It is well absorbed from the gastrointestinal tract, but its oral bioavailability is low (60%) due to extensive first-pass metabolism 
which makes it an ideal candidate for rapid release drug delivery system. In the present work we have prepared and evaluated fast dissolving 
oral films of Granisetron hydrochloride by solvent casting method using different concentrations polymers HPMC, PVA and their  combinations. 
Mannitol was used as a disintegrating agent and Propylene glycol as a plasticizer. The prepared oral films were evaluated for Physical 
appearance, texture, Weight uniformity, thickness uniformity, percentage moisture absorption, disintegration time, drug conte nt uniformity, 
folding endurance, tensile strength, in-vitro drug release, and stability studies. In-vitro release rate of Granisetron hydrochloride was studied in 
phosphate buffer pH 6.8. F1, F5 and F7 showed maximum release rate about 94.95%, 95.98% and 96.29% in 180 seconds respectively, whereas 
F3 showed 60.98%. Short term stability studies of selected films indicated that there is no significant change with respect to physical 
appearance, disintegration time, drug content and in-vitro drug release. 
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INTRODUCTION 
Drug delivery may be defined as the method or process of 
administering an active pharmaceutical ingredients and 
delivering to the desired site inside the body to elicit its 
therapeutic effect. Oral route is one of the most popular, 
preferable and convenient route for drug administration. It 
possesses certain advantages like ease of administration, self 
medication, patient compliance and flexibility with a wide 
range of dosage form 1. However researchers are seeking to 
incorporate various technologies in oral formulations to 
make them more efficacious 2.  
Recently, fast-dissolving drug delivery systems have started 
gaining popularity and acceptance as new drug delivery 
systems, which aim to enhance safety and efficacy of a drug 
molecule by formulating it into a convenient dosage form for 
administration and to achieve better patient compliance. It 
improves the efficacy of APIs by dissolving within minute in 
oral cavity after the contact with saliva without chewing and 
no need of water for administration. It gives quick 
absorption and instant bioavailability of drugs due to high 
blood flow and permeability of oral mucosa is many times 
greater than that of skin 3-4. Along with the local action these 
oral films are useful in patients such as pediatric, geriatrics, 
bedridden, emetic patients, diarrhea, sudden episode of 
allergic attacks, or coughing for those who have an active life 
style 5. 
Granisetron hydrochloride is a novel serotonin 5-
HT3 receptor antagonist used as an antiemetic to treat 
nausea and vomiting following chemotherapy 6. It is well 
absorbed from the gastrointestinal tract, but its oral 
bioavailability is low (60%) due to extensive first-pass 
metabolism which makes it an ideal candidate for rapid 
release drug delivery system 7. Hence, an attempt was made 
to prepare and evaluate fast dissolving oral films containing 
Granisetron hydrochloride as a model drug by solvent 
casting method using natural and synthetic polymers.  
MATERIALS AND METHODS 
Materials 
Granisetron HCl was obtained as gift sample from Salvavidas 
Pharmaceutical Pvt. Ltd, Surat. Polvinyl alcohol, HPMC K15 
and Propylene glycol were purchased from SD–Fine 
chemicals, Mumbai. All other chemicals and reagents were of 
analytical reagent grade. 
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Methods  
Formulation of fast-dissolving films 
In the present study, fast-dissolving films of Granisetron HCl 
were prepared by a solvent casting technique. Flat, square-
shaped, aluminum foil-coated glass molds having a surface 
area of 25 cm were fabricated for casting the films. The 
weighed quantities of polymers were kept for swelling 
overnight in distilled water and dissolved. The drug and 
aspartame were dissolved in distilled water and added to the 
above mentioned polymer solution along with propylene 
glycol as a plasticizer, mixed thoroughly to form a 
homogenous mixture. The volume was made up to 10 ml 
with distilled water. Entrapped air bubbles were removed by 
applying vacuum. 
The casting solution (10 ml) was poured into glass molds 
and dried at 40°C in a vacuum oven for 24 h for solvent 
evaporation. The films were removed by peeling and cut into 
a square dimension of 2.5 cm × 2.5 cm (6.25 cm2). It was 
dried for 24 hours at room temperature. The film was 
removed from the Petri dish very carefully and observed for 
any imperfections. Film that was clear and bubble free was 
selected for further studies. Composition of various 
formulations is shown in table-1, where fast-dissolving films 
were prepared with different polymers and ratios by 
maintaining the concentration of the plasticizer and 
sweetener constant. 
 
Table-1 Formulation of Fast dissolving films 
Code HPMC (mg) PVP K-30 
(mg) 
Granisetron HCl 
(mg) 
Propylene Glycol 
(ml) 
Aspartame
(mg) 
Distilled 
Water (ml) 
F1 100 - 20 0.1 40 10 
F2 - 100 20 0.1 40 10 
F3 50 50 20 0.1 40 10 
 
Thickness of the film 
The thickness of the patch was measured using digital 
Vernier Calipers with a least count of 0.01 mm at different 
spots of the film. The thickness was measured at three 
different spots of the patch and average was taken and SD 
was calculated (table-2). 
Drug content uniformity 
Prepared fast-dissolving film was dissolved in 100 ml of 
distilled water and filtered. After suitable dilutions with 
distilled water, the concentration of the drug was 
determined by measuring the absorbance at 230 nm against 
the distilled water as blank 11. 
Disintegration time 
Test was performed using disintegration test apparatus. 6.25 
cm2 film was placed in the basket, raised and lowered it in 
such a manner that the complete up and down movement at 
a rate equivalent to thirty times a minute. Time required by 
the film, when no traces of film remain above the gauze was 
noted (table-2). 
Folding endurance  
The folding endurance is expressed as the number of folds 
(number of times the film is folded at the same place) 
required to break the specimen or to develop visible cracks. 
This also gives an indication of brittleness of the film. A strip 
of 5 cm × 5 cm was subjected to folding endurance by folding 
the film at the same place repeatedly several times until a 
visible crack was observed, and the values were reported 11. 
 
Table-2 Physicochemical properties of prepared patches 
Code Thickness 
(mm) 
Flexibility Drug Content (%) Disintegration 
time (s) 
F1 0.144±0.018 Flexible 95.45±1.09 10 
F2 0.168±0.016 Flexible 98.59±1.04 8 
F3 0.165±0.025 Flexible 94.25±1.15 11 
 
 
In vitro dissolution studies 
The simulated salivary fluid was taken as the dissolution 
medium to determine the drug release. 
The dissolution profile of quick release films of Granisetron 
HCl was carried out in a beaker containing 30 ml of the 
simulated salivary fluid (pH 6.8) as a dissolution medium, 
maintained at 37 ± 0.5°C. The medium was stirred at 100 
rpm. Aliquots (5ml) of the dissolution medium were 
withdrawn at 15, 30, 60, 90and 120 s time intervals and 
samples were assayed spectrophotometerically at 230 nm. 
The percentage of the drug dissolved at various time 
intervals was calculated and plotted against time (Figure 1). 
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Figure 1 Comparison of in vitro percentage drug release of all formulations 
 
Stability studies 
The stability study of the formulated fast-dissolving films 
was carried out under different environmental conditions of 
2-8°C (45% RH), 25-30°C (60% RH), and 45-50°C (75% RH) 
for a period of 45 days. The films were characterized for the 
drug content and other parameters during the stability study 
period 11. 
RESULTS AND DISCUSSION 
Fast-dissolving films of Granisetron HCl were prepared by 
the solvent casting method on glass molds, using HPMC K15 
and PVA as polymers, Propylene glycol as plasticizer and 
aspartame as sweetener and Distilled water as a solvent. The 
effect of the nature of polymers was studied by preparing 
various formulations of fast-dissolving films. In all these 
formulations, a constant amount of drug (20 mg) was 
maintained. The characterization of prepared fast dissolving 
films were done for various parameters like thickness of the 
films, Drug content uniformity, Folding endurance of the 
films, Disintegration time, In-vitro dissolution and stability 
studies. It was observed that there was no significant 
difference in the thickness among the films, which indicated 
that the films were uniform. Drug content of F1, F2 and F3 
formulations was found to be 95.45±1.09, 98.59±1.04 and 
94.25±1.15% (table-2). 
From the in vitro drug release, it was observed that in 
formulations containing a single polymer, the drug release 
was found to be faster and films formed of PVA polymer 
resulted in a fastest release of drug. The drug release was 
found to be in the following order: F2 > F1 > F3. Stability 
study for the prepared film was carried out for 45 days at 
different temperature and humidity conditions. Fast-
dissolving films were found to be physically and chemically 
stable as they showed no significant change in terms of 
physical characteristics and drug content at a lower 
temperature and room temperature. However, when stored 
at 45-50°C for 45 days, films became brittle. 
CONCLUSIONS 
The aim of the present study was design formulation and 
evaluation of fast dissolving films of Granisetron HCl using 
various polymers. Fast-dissolving films were developed by 
solvent casting method and evaluated for different 
physicochemical properties. All formulations showed good 
results for thickness, drug content, disintegration time and 
folding endurance. In vitro release profile of the prepared 
films showed the effect of type of different polymers. Based 
on physicochemical parameters and in vitro release profile 
formulation F2 can be considered as the best formulation. 
The conclusion from all encouraging results reaches that 
fast-dissolving films of Granisetron HCl may be more suitable 
for clinical use in the treatment of severe vomiting 
conditions during chemotherapy, where a quicker onset of 
action for a dosage form is desirable.   
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